Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 29, 2012

Uncertainty Surrounds Proposed 2013 Budget for FDA and CDC, GEN Poll Suggests

  • A plurality of those who took a recent GEN poll isn’t sure what to make of President Barack Obama’s proposed FDA and CDC budgets for the 2013 fiscal year. When asked how helpful they thought Obama’s proposed budget would be for both agencies, 42.9% were “undecided,” another 28.6% replied “not much,” while even percentages (14.3% each) took a more optimistic view, saying the FY 2013 budget would be “very” or “somewhat” helpful.

    Under the president’s budget, FDA would see its budgetary authority inch up by 0.4% to $2.517 billion. When industry user fees are included, however, FDA’s total program spending would jump 17% to $4.486 billion. CDC would see its discretionary budget authority shrink by 11.6%, or $664 million, to $5.068 billion. After nondiscretionary spending is factored in, total CDC funding rises by 0.4% to $11.236 billion in FY ’13.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »